(Q39873073)

15 September 2017

title

Dendritic cells with transduced survivin gene induce specific cytotoxic T lymphocytes in human urologic cancer cell lines (English)

1 reference

15 September 2017

1 reference

Kazuro Kikkawa

1

1 reference

15 September 2017

Reona Fujii

2

1 reference

15 September 2017

Tomomi Kuramoto

3

1 reference

15 September 2017

Takashi Mori

4

1 reference

15 September 2017

Takeshi Inagaki

5

1 reference

15 September 2017

Yasuo Kohjimoto

6

1 reference

15 September 2017

Makoto Iwahashi

7

1 reference

15 September 2017

Hiroki Yamaue

8

1 reference

15 September 2017

Isao Hara

9

1 reference

15 September 2017

language of work or name

English

0 references

publication date

13 March 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

74

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

222-228

1 reference

Survivin as a target for new anticancer interventions

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.12.045

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.12.045

Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.12.045

High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.12.045

Survivin expression is associated with features of biologically aggressive prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.12.045

Control of apoptosis and mitotic spindle checkpoint by survivin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.12.045

Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.12.045

Survivin mediates resistance to antiandrogen therapy in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.12.045

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.12.045

Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.12.045

Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.12.045

10.1016/J.UROLOGY.2008.12.045

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference